Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
FRA:E9Q's 9-Day RSI is ranked worse than 84.22% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 46.67
vs FRA:E9Q: 61.78
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Guangdong Kanghua Healthcare Group Co 9-Day RSI Related Terms
FRA:E9Q vs HCA, THC, EHC: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's 9-Day RSI falls into.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a 9-Day RSI of 61.78 as of Sep. 15, 2026. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #587 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 84.2%.
Is Guangdong Kanghua Healthcare Group Co's 9-Day RSI too high?
Guangdong Kanghua Healthcare Group Co's current 9-Day RSI is 61.78. The Healthcare Providers & Services industry median 9-Day RSI is 46.67. Guangdong Kanghua Healthcare Group Co's value of 61.78 is 32.4% above this industry median. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #587 out of 697 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #587 out of 697 companies for 9-Day RSI. This places Guangdong Kanghua Healthcare Group Co in the lower half of its industry. The industry median 9-Day RSI is 46.67. Guangdong Kanghua Healthcare Group Co's value of 61.78 is 32.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 46.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Kanghua Healthcare Group Co's current 9-Day RSI of 61.78 is 32.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 46.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current 9-Day RSI is 61.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current 9-Day RSI of 61.78. The stock's GF Value™ is €0.20, compared to a current price of €0.19 — trading 7.5% below its estimated fair value. The current 9-Day RSI is 61.78 and 32.4% above the Healthcare Providers & Services industry median of 46.67. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current 9-Day RSI is 61.78 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.19 is trading 7.5% below its estimated GF Value™ of €0.20.
Key valuation signals for FRA:E9Q:
9-Day RSI: 61.78
GF Value™: €0.20 vs. price of €0.19 (7.5% below fair value)
Industry Position: 32.4% above the Healthcare Providers & Services median (#587 of 697)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
74GF Score
Get the complete analysis for FRA:E9Q
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
